FDA’s Woodcock Talks About Advancing Innovation at 2014 RAPS
Posted 16 October 2014 | By
During the first day of 2014 RAPS: The Regulatory Convergence on 29 September 2014, Janet Woodcock, director of the US Food and Drug Administration’s Center for Drug Evaluation and Research spoke to attendees via a pre-recorded video. Woodcock covered some important initiatives and changes in drug development and regulation and the importance of finding more efficient ways to present clinical evidence to help translate medical innovations into therapies more quickly. She talked about a number of FDA initiatives aimed at speeding needed new medicines to patients. Her presentation was part of a session titled, Focusing on the Patient: Advancing Innovation Through TransCelerate.